Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 1

Conditions

Breast Neoplasms 19Carcinoma, Non-Small-Cell Lung 9Rhabdomyosarcoma 6Triple Negative Breast Neoplasms 5Hodgkin Disease 4Recurrence 3Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Neoplasm Metastasis 2Lung Neoplasms 2Adenocarcinoma 2Solitary Fibrous Tumor, Pleural 1NSCLC 1Metastatic HER2-positive Breast Cancer 1Mesothelioma, Malignant 1Lung Diseases, Interstitial 1Locally Advanced Non-Small Cell Lung Cancer 1HR+HER2- Breast Cancer 1Fludzoparib" and Anti-angiogenic 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Advanced Breast Cancer 1

Interventions

pembrolizumab 90Blood Specimen Collection 41Cyclophosphamide 37Bevacizumab 36Nivolumab 35Standard of Care 32Carboplatin 31Surveys and Questionnaires 29Paclitaxel 27atezolizumab 25Exercise 25Pemetrexed 24Gemcitabine 23Cisplatin 23Fluorouracil 22Radiotherapy 20Leucovorin 20Dexamethasone 20Docetaxel 19Oxaliplatin 18Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Drug Therapy 15Doxorubicin 15Ipilimumab 14Biopsy 14130-nm albumin-bound paclitaxel 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Vinorelbine × 1 year × Clear all
NCT05999994 2026-03-27

CAMPFIRE

Eli Lilly and Company

Phase 2 Recruiting
105 enrolled
Tumor-Agnostic

Neoplasms

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting
472 enrolled
Tumor-Agnostic

Neoplasms

NCT04759248 2025-09-09

ATREZZO

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
55 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡